Nigel McCracken, chief operating officer, Virax Biolabs, discusses results from new data on the role of T cell dysfunction in ...

Nigel McCracken, chief operating officer, Virax Biolabs, discusses new findings that reveal altered cytokine activity and ...

3 German Centre for Infection Research (Deutsches Zentrum für Infektionsforschung DZIF), Partner Site Hannover-Braunschweig, Hannover, Germany 4 Computational Biology for Individualised Medicine, ...

Patients with cirrhosis are at an increased risk of bacterial infection (BI), which is the most common precondition for acute-on-chronic liver failure ...

The scientists showed that, right at the onset of mild illness, the body also produces special T cells previously known only from chronic, severe infections and tumors. There are different types ...

T cells are the most abundant lymphocyte ... Lymphocytosis is common with both acute (sudden and short-lived) and chronic (persistent or recurrent) infections. It can also occur with certain cancers ...

This discovery has important implications for immunotherapies, particularly those used in cancer and chronic infections, where T-cell activation and desensitization cycles play a critical role.

The scientists showed that, right at the onset of mild illness, the body also produces special T cells previously known only from chronic, severe infections and tumors. Even in the case of ...

Strong immune resilience between 40–70 cuts early death risk by 69%, preserves brain health, and boosts vaccine responses.

Researchers from TUM and Helmholtz Munich discovered that even in mild infections, the body prepares T cells that are predisposed to exhaustion. These T cells, typically seen in chronic infections and ...

A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously unknown phase of the immune response. The results, published in Science, ...